摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-(4-((N-(3-(4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl)propyl)-2-(4-methylpiperazin-1-yl)acetamido)methyl)phenyl)acetate | 1080009-57-9

中文名称
——
中文别名
——
英文名称
methyl 2-(4-((N-(3-(4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl)propyl)-2-(4-methylpiperazin-1-yl)acetamido)methyl)phenyl)acetate
英文别名
Methyl 2-[4-[[3-[4-amino-2-(2-methoxyethyl)imidazo[4,5-c]quinolin-1-yl]propyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]methyl]phenyl]acetate
methyl 2-(4-((N-(3-(4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl)propyl)-2-(4-methylpiperazin-1-yl)acetamido)methyl)phenyl)acetate化学式
CAS
1080009-57-9
化学式
C33H43N7O4
mdl
——
分子量
601.749
InChiKey
JAFVJOPWLXIGNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    44
  • 可旋转键数:
    14
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    119
  • 氢给体数:
    1
  • 氢受体数:
    9

文献信息

  • IMIDAZOQUINOLINES WITH IMMUNO-MODULATING PROPERTIES
    申请人:Bonnert Roger Victor
    公开号:US20100280001A1
    公开(公告)日:2010-11-04
    The present invention provides compounds of formula (I) wherein R a , R 1 , R 2 , R 3 , X 1 , Y 1 , Z 1 , A, n and m are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    本发明提供了式(I)的化合物,其中Ra、R1、R2、R3、X1、Y1、Z1、A、n和m如规范中定义,以及其药学上可接受的盐,以及它们的制备方法、含有它们的制药组合物和它们在治疗中的应用。
  • Imidazoquinolines with Immuno-Modulating Properties
    申请人:AstraZeneca AB
    公开号:US20130225555A1
    公开(公告)日:2013-08-29
    The present invention provides compounds of formula (I) wherein R a , R 1 , R 2 , R 3 , X 1 , Y 1 , Z 1 , A, n and m are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    本发明提供了式(I)的化合物,其中Ra,R1,R2,R3,X1,Y1,Z1,A,n和m如规范中所定义,并且其药学上可接受的盐,以及它们的制备方法,含有它们的制药组合物和它们在治疗中的应用。
  • REFORMING CATALYST PREPARATION BY DRY IMPREGNATION
    申请人:OUDART Yohan
    公开号:US20100285953A1
    公开(公告)日:2010-11-11
    The invention relates to a method of preparing a reforming catalyst comprising a group VIII metal, a halogen, at least one metal selected from the group made up of the group VIIB metals and group IVA metals, a refractory oxide support. The method comprises stages of preparing a dry impregnation aqueous solution containing ammonia, either in solution or in gas form and a complexing agent, of aging the aqueous solution, of dry impregnation of the support, of maturing the impregnated support, of drying and of calcination.
  • US8283280B2
    申请人:——
    公开号:US8283280B2
    公开(公告)日:2012-10-09
  • US8436178B2
    申请人:——
    公开号:US8436178B2
    公开(公告)日:2013-05-07
查看更多